Kelsey Pilewski

Originally from upstate New York, Kelsey received her undergraduate degrees in Biochemistry and French from the University at Buffalo in 2016. Kelsey joined the Georgiev Lab in 2017 to complete her thesis research investigating the discovery and characterization of antibody and vaccine candidates against a number of pathogens. She received her PhD from Vanderbilt University in March 2022 and joined the lab as a postdoctoral fellow shortly after, where she is now working to expand the discovery capabilities of LIBRA-seq. Outside of lab, Kelsey can be found hiking or baking.